Grant: Fellowship - PA - Hepatology
University of Alberta
$67,500.00
Prognostic Value of a Prospective, Longitudinal Evaluation of Body Composition in Patients with Cirrhosis Evaluated for Liver Transplantation
EF 2018-19
Résumé
Two main body compartments, skeletal muscle and adipose tissue (fat), exhibit independent functions. Patients with liver cirrhosis frequently experience body composition abnormalities including loss of muscle and subcutaneous fat but not visceral fat (around internal organs). Liver cirrhosis, characterized by liver failure and replacement of normal tissue by scarring is the main indication for liver transplantation. These body composition abnormalities are associated with higher risk of complications such as infections, longer recovery after surgeries, and higher probability of death. The aim of this study is to evaluate muscle and subcutaneous fat abnormalities in relation to adverse outcomes both before and after liver transplantation. Muscle and fat amount and condition will be assessed using high resolution image-based techniques (computed tomography) at 6-month intervals in cirrhotic patients being evaluated for liver transplantation. During liver transplantation surgery, a small biopsy of muscle and fat will be obtained for analysis of cell types and signals. This information will establish the real burden of body composition abnormalities and their behavior in patients with cirrhosis over time to improve the prediction of outcomes, identify potential targets for treatment, and facilitate development of clinical trials for these conditions.
Programme
Fellowship - PA - Hepatology
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
399643
Name
Ebadi Maryam
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Liver Canada (Markham, Ontario); The Canadian Association for the Study of Liver
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Health Research Training B - HP
Projecttitle
Prognostic Value of a Prospective, Longitudinal Evaluation of Body Composition in Patients with Cirrhosis Evaluated for Liver Transplantation
Programtype2
Fellowship Programs
Orgnameinp2
University of Alberta
Cihramount2
$67,500
Cihrequipment2
$0
Programname2
Fellowship - PA - Hepatology
Keyworddelim
Abnormal Body Composition Phenotypes; Competing Risk Analysis; Computed Tomography; Discriminative Mortality Model; Lipidomic; Lipodystrophy; Liver Transplant Mortality; Metabolic Pathways; Proteomic; Sarcopenia
Abstract
Two main body compartments, skeletal muscle and adipose tissue (fat), exhibit independent functions. Patients with liver cirrhosis frequently experience body composition abnormalities including loss of muscle and subcutaneous fat but not visceral fat (around internal organs). Liver cirrhosis, characterized by liver failure and replacement of normal tissue by scarring is the main indication for liver transplantation. These body composition abnormalities are associated with higher risk of complications such as infections, longer recovery after surgeries, and higher probability of death. The aim of this study is to evaluate muscle and subcutaneous fat abnormalities in relation to adverse outcomes both before and after liver transplantation. Muscle and fat amount and condition will be assessed using high resolution image-based techniques (computed tomography) at 6-month intervals in cirrhotic patients being evaluated for liver transplantation. During liver transplantation surgery, a small biopsy of muscle and fat will be obtained for analysis of cell types and signals. This information will establish the real burden of body composition abnormalities and their behavior in patients with cirrhosis over time to improve the prediction of outcomes, identify potential targets for treatment, and facilitate development of clinical trials for these conditions.
Competitiondate
201811
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ebadi, Maryam
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $67,500~ $0~